Asahi Ito

1.9k total citations
68 papers, 1.4k citations indexed

About

Asahi Ito is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Asahi Ito has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 20 papers in Hematology and 19 papers in Molecular Biology. Recurrent topics in Asahi Ito's work include T-cell and Retrovirus Studies (25 papers), Multiple Myeloma Research and Treatments (14 papers) and Immune Cell Function and Interaction (13 papers). Asahi Ito is often cited by papers focused on T-cell and Retrovirus Studies (25 papers), Multiple Myeloma Research and Treatments (14 papers) and Immune Cell Function and Interaction (13 papers). Asahi Ito collaborates with scholars based in Japan, Germany and Egypt. Asahi Ito's co-authors include Takashi Ishida, Shinsuke Iida, Shigeru Kusumoto, Ryuzo Ueda, Hirokazu Komatsu, Masaki Ri, Hiroshi Inagaki, Atsushi Inagaki, Fumiko Mori and Fumihiko Sato and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Asahi Ito

67 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asahi Ito Japan 20 556 543 382 253 181 68 1.4k
Seiichi Okabe Japan 18 170 0.3× 404 0.7× 273 0.7× 417 1.6× 34 0.2× 92 969
H Hirai Japan 16 227 0.4× 596 1.1× 332 0.9× 321 1.3× 19 0.1× 36 1.1k
Sabine Cerny‐Reiterer Austria 29 692 1.2× 808 1.5× 453 1.2× 849 3.4× 20 0.1× 65 2.2k
Valerie I. Brown United States 21 298 0.5× 727 1.3× 515 1.3× 333 1.3× 10 0.1× 44 1.5k
L. Mengle-Gaw United Kingdom 16 521 0.9× 401 0.7× 137 0.4× 98 0.4× 11 0.1× 20 1.1k
Janet M.D. Plate United States 18 807 1.5× 402 0.7× 557 1.5× 60 0.2× 8 0.0× 48 1.4k
Emanuela Ottaviani Italy 25 293 0.5× 1.1k 2.1× 364 1.0× 1.5k 6.0× 17 0.1× 147 2.4k
Jin Hong Liu United States 14 689 1.2× 437 0.8× 437 1.1× 110 0.4× 6 0.0× 15 1.3k
Xinming Su United States 15 615 1.1× 424 0.8× 613 1.6× 65 0.3× 8 0.0× 38 1.2k

Countries citing papers authored by Asahi Ito

Since Specialization
Citations

This map shows the geographic impact of Asahi Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asahi Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asahi Ito more than expected).

Fields of papers citing papers by Asahi Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asahi Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asahi Ito. The network helps show where Asahi Ito may publish in the future.

Co-authorship network of co-authors of Asahi Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Asahi Ito. A scholar is included among the top collaborators of Asahi Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asahi Ito. Asahi Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ri, Masaki, Arisa Asano, Shiori Kinoshita, et al.. (2024). Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone. Cancer Medicine. 13(14). e70019–e70019. 1 indexed citations
2.
Sakamoto, Yuma, Takashi Ishida, Ayako Masaki, et al.. (2022). CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment. Hematological Oncology. 40(5). 876–884. 7 indexed citations
3.
Sakamoto, Yuma, Takashi Ishida, Ayako Masaki, et al.. (2021). Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma. British Journal of Haematology. 195(4). 571–584. 12 indexed citations
4.
Sakamoto, Yuma, Takashi Ishida, Ayako Masaki, et al.. (2021). Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma. Cancer Science. 113(1). 349–361. 10 indexed citations
5.
Shinjo, Keiko, Miho Suzuki, Keisuke Katsushima, et al.. (2020). Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma. Oncogene. 39(35). 5782–5794. 5 indexed citations
6.
Sakamoto, Yuma, Ayako Masaki, Takayuki Murase, et al.. (2020). Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma. The Journal of Pathology Clinical Research. 7(1). 52–60. 11 indexed citations
7.
Sakamoto, Yuma, Takashi Ishida, Ayako Masaki, et al.. (2020). Clinical significance of CD28 gene‐related activating alterations in adult T‐cell leukaemia/lymphoma. British Journal of Haematology. 192(2). 281–291. 12 indexed citations
8.
Ishii, Toshihiko, Itaru Urakawa, Ayako Masaki, et al.. (2020). Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma. Blood Advances. 4(10). 2180–2191. 16 indexed citations
9.
Kinoshita, Shiori, Masaki Ri, Arisa Asano, et al.. (2020). Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma. Cancer Science. 111(4). 1333–1343. 20 indexed citations
10.
Ishii, Toshihiko, Itaru Urakawa, Ayako Masaki, et al.. (2019). Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma. Clinical Cancer Research. 25(14). 4388–4399. 20 indexed citations
11.
Ri, Masaki, Takashi Yoshida, Shiori Kinoshita, et al.. (2019). Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma. International Journal of Hematology. 110(1). 69–76. 10 indexed citations
12.
Yoshida, Takashi, Masaki Ri, Hirokazu Sasaki, et al.. (2019). Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma. International Journal of Hematology. 110(2). 228–236. 5 indexed citations
13.
Masaki, Ayako, Takashi Ishida, Susumu Suzuki, et al.. (2018). Human T‐cell lymphotropic/leukemia virus type 1 (HTLV‐1) Tax‐specific T‐cell exhaustion in HTLV‐1‐infected individuals. Cancer Science. 109(8). 2383–2390. 23 indexed citations
14.
Yoshida, Takashi, Masaki Ri, Shiori Kinoshita, et al.. (2018). Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma. PLoS ONE. 13(5). e0196780–e0196780. 18 indexed citations
15.
Masaki, Ayako, Takashi Ishida, Yasuhiro Maeda, et al.. (2017). Clinical significance of tryptophan catabolism in Hodgkin lymphoma. Cancer Science. 109(1). 74–83. 22 indexed citations
16.
Masaki, Ayako, Takashi Ishida, Yasuhiro Maeda, et al.. (2015). Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma. Clinical Cancer Research. 21(12). 2830–2839. 42 indexed citations
17.
Suzuki, Tomotaka, Shigeru Kusumoto, Taro Yamashita, et al.. (2015). Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis. Annals of Hematology. 95(2). 279–285. 28 indexed citations
18.
Yano, Hiroki, Takashi Ishida, Atsushi Inagaki, et al.. (2009). [Anti-CCR4 monoclonal antibody as a novel therapy for advanced mycosis fungoides and Sézary syndrome].. PubMed. 50(12). 1671–8. 1 indexed citations
19.
Inagaki, Atsushi, Takashi Ishida, Hiroki Yano, et al.. (2009). Expression of the ULBP ligands for NKG2D by B‐NHL cells plays an important role in determining their susceptibility to rituximab‐induced ADCC. International Journal of Cancer. 125(1). 212–221. 27 indexed citations
20.
Ito, Asahi, Takashi Ishida, Hiroki Yano, et al.. (2008). Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model. Cancer Immunology Immunotherapy. 58(8). 1195–1206. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiichi Okabe Breakdown of academic impact, for papers by H Hirai Breakdown of academic impact, for papers by Sabine Cerny‐Reiterer Breakdown of academic impact, for papers by Valerie I. Brown Breakdown of academic impact, for papers by L. Mengle-Gaw Breakdown of academic impact, for papers by Janet M.D. Plate Breakdown of academic impact, for papers by Emanuela Ottaviani Breakdown of academic impact, for papers by Jin Hong Liu Breakdown of academic impact, for papers by Xinming Su
Rankless by CCL
2026